Fluorine in PDB 5ae2: Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E
Protein crystallography data
The structure of Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E, PDB code: 5ae2
was solved by
V.Piano,
D.I.Benjamin,
S.Valente,
S.Nenci,
B.Marrocco,
A.Mai,
A.Aliverti,
D.K.Nomura,
A.Mattevi,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
107.06 /
2.00
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
60.530,
98.570,
107.070,
90.57,
90.14,
95.67
|
R / Rfree (%)
|
17.501 /
22.882
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E
(pdb code 5ae2). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E, PDB code: 5ae2:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 5ae2
Go back to
Fluorine Binding Sites List in 5ae2
Fluorine binding site 1 out
of 4 in the Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F888
b:59.8
occ:1.00
|
F1
|
A:FYC888
|
0.0
|
59.8
|
1.0
|
C16
|
A:FYC888
|
1.3
|
61.2
|
1.0
|
C15
|
A:FYC888
|
2.3
|
60.6
|
1.0
|
C11
|
A:FYC888
|
2.4
|
61.2
|
1.0
|
C10
|
A:FYC888
|
2.9
|
54.4
|
1.0
|
C
|
A:GLU526
|
3.4
|
24.1
|
1.0
|
N
|
A:GLU526
|
3.4
|
25.1
|
1.0
|
O
|
A:GLU526
|
3.4
|
22.1
|
1.0
|
CD1
|
A:TYR580
|
3.4
|
33.5
|
1.0
|
C14
|
A:FYC888
|
3.6
|
64.1
|
1.0
|
C8
|
A:FYC888
|
3.6
|
50.5
|
1.0
|
CA
|
A:GLU526
|
3.6
|
27.5
|
1.0
|
C12
|
A:FYC888
|
3.6
|
63.3
|
1.0
|
N
|
A:SER527
|
3.9
|
20.5
|
1.0
|
C
|
A:GLY525
|
3.9
|
25.8
|
1.0
|
O
|
A:PHE581
|
3.9
|
24.0
|
1.0
|
CB
|
A:TYR580
|
3.9
|
28.7
|
1.0
|
C9
|
A:FYC888
|
4.0
|
54.1
|
1.0
|
C13
|
A:FYC888
|
4.1
|
66.0
|
1.0
|
CG
|
A:TYR580
|
4.1
|
30.3
|
1.0
|
N
|
A:PHE581
|
4.3
|
23.4
|
1.0
|
CE1
|
A:TYR580
|
4.4
|
35.3
|
1.0
|
CA
|
A:TYR580
|
4.4
|
25.0
|
1.0
|
CA
|
A:GLY525
|
4.4
|
26.9
|
1.0
|
O
|
A:GLY525
|
4.5
|
26.4
|
1.0
|
CA
|
A:SER527
|
4.6
|
22.8
|
1.0
|
O2
|
A:FYC888
|
4.6
|
44.6
|
1.0
|
C7
|
A:FYC888
|
4.6
|
45.6
|
1.0
|
C
|
A:PHE581
|
4.6
|
23.4
|
1.0
|
C
|
A:TYR580
|
4.8
|
25.1
|
1.0
|
CB
|
A:SER527
|
4.8
|
23.5
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 5ae2
Go back to
Fluorine Binding Sites List in 5ae2
Fluorine binding site 2 out
of 4 in the Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F888
b:62.8
occ:1.00
|
F1
|
B:FYC888
|
0.0
|
62.8
|
1.0
|
C16
|
B:FYC888
|
1.3
|
58.8
|
1.0
|
C15
|
B:FYC888
|
2.3
|
55.6
|
1.0
|
C11
|
B:FYC888
|
2.4
|
55.9
|
1.0
|
C10
|
B:FYC888
|
2.8
|
55.1
|
1.0
|
C
|
B:GLU526
|
3.1
|
27.4
|
1.0
|
CD1
|
B:TYR580
|
3.1
|
36.4
|
1.0
|
O
|
B:GLU526
|
3.2
|
22.0
|
1.0
|
N
|
B:GLU526
|
3.4
|
32.6
|
1.0
|
N
|
B:SER527
|
3.5
|
25.0
|
1.0
|
CA
|
B:GLU526
|
3.5
|
31.3
|
1.0
|
C14
|
B:FYC888
|
3.6
|
57.1
|
1.0
|
C12
|
B:FYC888
|
3.7
|
57.4
|
1.0
|
C8
|
B:FYC888
|
3.8
|
53.4
|
1.0
|
CB
|
B:TYR580
|
3.8
|
27.8
|
1.0
|
CG
|
B:TYR580
|
3.8
|
32.9
|
1.0
|
C
|
B:GLY525
|
4.0
|
30.9
|
1.0
|
CE1
|
B:TYR580
|
4.0
|
39.0
|
1.0
|
O
|
B:PHE581
|
4.1
|
26.5
|
1.0
|
C13
|
B:FYC888
|
4.1
|
57.6
|
1.0
|
CA
|
B:TYR580
|
4.2
|
26.1
|
1.0
|
CA
|
B:SER527
|
4.2
|
26.6
|
1.0
|
O2
|
B:FYC888
|
4.3
|
49.3
|
1.0
|
N
|
B:PHE581
|
4.3
|
21.8
|
1.0
|
CB
|
B:SER527
|
4.4
|
25.9
|
1.0
|
CA
|
B:GLY525
|
4.5
|
32.4
|
1.0
|
C9
|
B:FYC888
|
4.5
|
56.4
|
1.0
|
C7
|
B:FYC888
|
4.5
|
50.1
|
1.0
|
O
|
B:GLY525
|
4.7
|
26.5
|
1.0
|
C
|
B:TYR580
|
4.8
|
24.1
|
1.0
|
C
|
B:PHE581
|
4.9
|
25.9
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 5ae2
Go back to
Fluorine Binding Sites List in 5ae2
Fluorine binding site 3 out
of 4 in the Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F888
b:57.0
occ:1.00
|
F1
|
C:FYC888
|
0.0
|
57.0
|
1.0
|
C16
|
C:FYC888
|
1.3
|
51.2
|
1.0
|
C11
|
C:FYC888
|
2.3
|
49.6
|
1.0
|
C15
|
C:FYC888
|
2.3
|
52.7
|
1.0
|
C10
|
C:FYC888
|
2.7
|
47.3
|
1.0
|
CD1
|
C:TYR580
|
3.1
|
34.5
|
1.0
|
O
|
C:GLU526
|
3.1
|
21.1
|
1.0
|
C8
|
C:FYC888
|
3.1
|
42.7
|
1.0
|
C
|
C:GLU526
|
3.2
|
24.5
|
1.0
|
C9
|
C:FYC888
|
3.5
|
44.0
|
1.0
|
N
|
C:SER527
|
3.6
|
20.9
|
1.0
|
C12
|
C:FYC888
|
3.6
|
52.4
|
1.0
|
C14
|
C:FYC888
|
3.6
|
50.0
|
1.0
|
N
|
C:GLU526
|
3.6
|
25.4
|
1.0
|
CA
|
C:GLU526
|
3.7
|
27.4
|
1.0
|
CB
|
C:TYR580
|
3.8
|
28.1
|
1.0
|
CG
|
C:TYR580
|
3.9
|
33.8
|
1.0
|
CE1
|
C:TYR580
|
4.0
|
35.2
|
1.0
|
C13
|
C:FYC888
|
4.1
|
51.2
|
1.0
|
CA
|
C:SER527
|
4.1
|
21.7
|
1.0
|
C
|
C:GLY525
|
4.2
|
27.2
|
1.0
|
C7
|
C:FYC888
|
4.2
|
41.1
|
1.0
|
CA
|
C:TYR580
|
4.2
|
25.4
|
1.0
|
O
|
C:PHE581
|
4.3
|
26.2
|
1.0
|
CB
|
C:SER527
|
4.3
|
21.9
|
1.0
|
O2
|
C:FYC888
|
4.3
|
45.0
|
1.0
|
N
|
C:PHE581
|
4.5
|
23.2
|
1.0
|
O
|
C:GLY525
|
4.7
|
24.3
|
1.0
|
CA
|
C:GLY525
|
4.8
|
28.1
|
1.0
|
C
|
C:TYR580
|
4.9
|
24.1
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 5ae2
Go back to
Fluorine Binding Sites List in 5ae2
Fluorine binding site 4 out
of 4 in the Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Ether Lipid-Generating Enzyme Agps in Complex with Inhibitor 1E within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F888
b:51.9
occ:1.00
|
F1
|
D:FYC888
|
0.0
|
51.9
|
1.0
|
C16
|
D:FYC888
|
1.3
|
55.0
|
1.0
|
C15
|
D:FYC888
|
2.3
|
57.5
|
1.0
|
C11
|
D:FYC888
|
2.4
|
55.4
|
1.0
|
C10
|
D:FYC888
|
2.9
|
51.4
|
1.0
|
CD1
|
D:TYR580
|
3.2
|
41.0
|
1.0
|
C
|
D:GLU526
|
3.2
|
24.6
|
1.0
|
O
|
D:GLU526
|
3.2
|
25.3
|
1.0
|
C8
|
D:FYC888
|
3.3
|
48.1
|
1.0
|
N
|
D:GLU526
|
3.4
|
25.9
|
1.0
|
C9
|
D:FYC888
|
3.4
|
45.9
|
1.0
|
C14
|
D:FYC888
|
3.6
|
58.7
|
1.0
|
N
|
D:SER527
|
3.6
|
24.1
|
1.0
|
CA
|
D:GLU526
|
3.6
|
26.8
|
1.0
|
C12
|
D:FYC888
|
3.6
|
56.6
|
1.0
|
CB
|
D:TYR580
|
3.6
|
30.7
|
1.0
|
CG
|
D:TYR580
|
3.8
|
37.0
|
1.0
|
C
|
D:GLY525
|
4.1
|
27.7
|
1.0
|
CA
|
D:TYR580
|
4.1
|
28.9
|
1.0
|
C13
|
D:FYC888
|
4.1
|
58.6
|
1.0
|
CE1
|
D:TYR580
|
4.2
|
39.2
|
1.0
|
CA
|
D:SER527
|
4.2
|
21.7
|
1.0
|
N
|
D:PHE581
|
4.2
|
27.1
|
1.0
|
O
|
D:PHE581
|
4.2
|
25.9
|
1.0
|
CB
|
D:SER527
|
4.3
|
22.1
|
1.0
|
C7
|
D:FYC888
|
4.5
|
47.1
|
1.0
|
CA
|
D:GLY525
|
4.5
|
27.8
|
1.0
|
C
|
D:TYR580
|
4.7
|
27.4
|
1.0
|
O2
|
D:FYC888
|
4.7
|
49.9
|
1.0
|
O
|
D:GLY525
|
4.7
|
28.8
|
1.0
|
C
|
D:PHE581
|
4.9
|
29.5
|
1.0
|
|
Reference:
V.Piano,
D.I.Benjamin,
S.Valente,
S.Nenci,
B.Marrocco,
A.Mai,
A.Aliverti,
D.K.Nomura,
A.Mattevi.
Discovery of Inhibitors For the Ether Lipid-Generating Enzyme Agps As Anti-Cancer Agents. Acs Chem.Biol. V. 10 2589 2015.
ISSN: ISSN 1554-8929
PubMed: 26322624
DOI: 10.1021/ACSCHEMBIO.5B00466
Page generated: Thu Aug 1 07:41:12 2024
|